Vulnerability · CVE-2026-34506
OpenClaw before 2026.3.8 contains a sender allowlist bypass vulnerability in its Microsoft Teams plugin that allows unauthorized senders to bypass intended authorization checks.
Published Mar 31, 2026 · catalog updated Jul 24, 2026 · OpenClaw before 2026.3.8 contains
Check if you run it
No confirmed exploitation is on record for CVE-2026-34506. EPSS is 0.34%. Act only if a listed version of OpenClaw before 2026.3.8 contains is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (OpenClaw before 2026.3.8 contains).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Low2.3
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.34%
- Remediation
- Advisory link
- Affected products
- cpe openclaw/openclaw
OpenClaw before 2026.3.8 contains a sender allowlist bypass vulnerability in its Microsoft Teams plugin that allows unauthorized senders to bypass intended authorization checks. When a team/channel route allowlist is configured with an empty groupAllowFrom parameter, the message handler synthesizes wildcard sender authorization, permitting any sender in the matched team/channel to trigger replies in allowlisted Teams routes.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe openclaw/openclawversion unspecified
How to fix CVE-2026-34506
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-34506. EPSS is 0.34%. Act only if a listed version of OpenClaw before 2026.3.8 contains is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-863: Incorrect Authorization. EPSS 0.34%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Mar 31, 2026 · NIST NVD
Detected
OpenClaw before 2026.3.8 contains a sender allowlist bypass vulnerability in its Microsoft Teams plugin that allows unauthorized senders to bypass intended authorization checks. When a team/channel route allowlist is configured with an empty groupAllowFrom parameter, the message handler synthesizes wildcard sender authorization, permitting any sender in the matched team/channel to trigger replies
Jul 24, 2026 · NIST NVD
Updated
OpenClaw before 2026.3.8 contains a sender allowlist bypass vulnerability in its Microsoft Teams plugin that allows unauthorized senders to bypass intended authorization checks. When a team/channel route allowlist is configured with an empty groupAllowFrom parameter, the message handler synthesizes wildcard sender authorization, permitting any sender in the matched team/channel to trigger replies
Sources
- CVE.orgVulnerability recordCVE-2026-34506
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-34506
30-day exploitation probability 0.3%
first.org - NIST NVDVulnerability recordCVE-2026-34506
OpenClaw before 2026.3.8 contains a sender allowlist bypass vulnerability in its Microsoft Teams plugin that allows unauthorized senders to bypass intended authorization checks. When a team/channel route allowlist is configured with an empty groupAllowFrom parameter, the message
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.